2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 23.879 | 44.171 | 62.231 | 68.824 | 148.518 | 157.298 | 159.042 | 168.853 | 174.704 | 193.088 |
Total Income - EUR | 23.882 | 44.171 | 62.499 | 68.824 | 148.927 | 157.299 | 159.043 | 168.854 | 174.705 | 193.090 |
Total Expenses - EUR | 15.642 | 30.772 | 39.209 | 43.301 | 98.590 | 95.467 | 101.793 | 140.862 | 131.734 | 131.132 |
Gross Profit/Loss - EUR | 8.240 | 13.399 | 23.290 | 25.523 | 50.337 | 61.832 | 57.249 | 27.992 | 42.971 | 61.958 |
Net Profit/Loss - EUR | 7.524 | 12.074 | 22.667 | 24.835 | 48.852 | 60.259 | 55.772 | 26.390 | 41.225 | 60.027 |
Employees | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 |
Check the financial reports for the company - Npa Med Srl
2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 580 | 664 | 548 | 1.893 | 1.418 | 7.182 | 40.466 | 30.542 | 31.112 | 20.651 |
Current Assets | 15.214 | 28.614 | 24.691 | 25.605 | 73.692 | 58.767 | 124.039 | 145.038 | 44.776 | 63.526 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Receivables | 1.855 | 4.457 | 5.102 | 6.421 | 13.657 | 15.141 | 15.005 | 16.034 | 15.629 | 54.198 |
Cash | 13.359 | 24.158 | 19.589 | 19.184 | 60.035 | 43.626 | 109.034 | 129.004 | 29.147 | 9.327 |
Shareholders Funds | 14.627 | 26.823 | 22.712 | 24.878 | 73.273 | 60.301 | 114.931 | 138.772 | 41.265 | 60.067 |
Social Capital | 45 | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 |
Debts | 1.167 | 2.455 | 2.527 | 2.619 | 1.837 | 5.648 | 49.574 | 36.808 | 34.623 | 24.109 |
Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "8621 - 8621" | |||||||||
CAEN Financial Year |
8621
|
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Comments - Npa Med Srl